<p>(a) The rate of miR-376a(e) in HFF cells either mock treated or HCMV infected was determined by next generation small RNA deep sequencing. Data are combined of two independent experiments. The rate in mock treated cells: 0.5943, in HCMV infected cells: 0.7912, *P-value: 4.38E-13. The rate of miR-376a(e) was calculated as the proportion of miR-376a(e) out of all the miR-376a species after allowing two mismatches. Hence no specific normalization was required. (b and c) WB analysis (b) and quantification (c) of ADAR1-p110 expression in mock treated or HCMV infected HFF cells transduced either with shADAR1 vector or with a control vector. (b) Data are representative of three independent experiments. Numbers indicate fold change in intensity ...
<p>(A) Analysis of miR-122 isomers identified by the deep sequencing of small RNA libraries from hum...
<p>(A) Relative Rluc:Fluc expression in Huh7.5 cells co-electroporated with full-length, replication...
<p>(A) After transfection of K562/ADM cells with mimics of miR-381, miR-495 or negative controls, or...
<p>(a–f) WB analysis of ADAR1 expression during various viral infections. (a) Time course analysis o...
(A) Quantification of ADAR1-edited transcripts (order as in S1 Table) in HeLa, p150KO, and ADAR1KO c...
<p>(A, C) HCMV genome copies in Kasumi-3 cells (A) and CD34<sup>+</sup> HPCs (C) infected with NR-1 ...
<p>(a) Schematic description of the alternative promoters of the ADAR1 gene (black arrows) and their...
<p>(a–d) ADAR1 levels were assessed in decidua organ culture 36 hr (a and b) and 7days (c and d) aft...
(A and B) Growth curve analyses of (A) MeV-vac2(GFP) and (B) MeV-CKO(GFP) in HeLa cell lines infecte...
(A) Western blot analysis of untreated and IFN A/D–treated ADAR1-modified cells. Cells were treated ...
<p>The representative sequencing results for miR-214 (<b>A</b>) and miR-122 (<b>B</b>), with the RT–...
<p>(<b>A</b>) The RNA extracted from Huh-7 cells infected with individual lenti-ADARs as indicated w...
<p>(A) Viability 48 hrs. post infection with MOI = 1.0 recombinant CVA21s in the presence of 200 nM ...
<p>(A) A miR-UL112-3p deficient AD169 virus fails to down-regulate endogenous TLR2 during infection....
<p>(A) HCC subjects were grouped based on clinical HBV indices including HbsAg, HbeAg and HBV-DNA (M...
<p>(A) Analysis of miR-122 isomers identified by the deep sequencing of small RNA libraries from hum...
<p>(A) Relative Rluc:Fluc expression in Huh7.5 cells co-electroporated with full-length, replication...
<p>(A) After transfection of K562/ADM cells with mimics of miR-381, miR-495 or negative controls, or...
<p>(a–f) WB analysis of ADAR1 expression during various viral infections. (a) Time course analysis o...
(A) Quantification of ADAR1-edited transcripts (order as in S1 Table) in HeLa, p150KO, and ADAR1KO c...
<p>(A, C) HCMV genome copies in Kasumi-3 cells (A) and CD34<sup>+</sup> HPCs (C) infected with NR-1 ...
<p>(a) Schematic description of the alternative promoters of the ADAR1 gene (black arrows) and their...
<p>(a–d) ADAR1 levels were assessed in decidua organ culture 36 hr (a and b) and 7days (c and d) aft...
(A and B) Growth curve analyses of (A) MeV-vac2(GFP) and (B) MeV-CKO(GFP) in HeLa cell lines infecte...
(A) Western blot analysis of untreated and IFN A/D–treated ADAR1-modified cells. Cells were treated ...
<p>The representative sequencing results for miR-214 (<b>A</b>) and miR-122 (<b>B</b>), with the RT–...
<p>(<b>A</b>) The RNA extracted from Huh-7 cells infected with individual lenti-ADARs as indicated w...
<p>(A) Viability 48 hrs. post infection with MOI = 1.0 recombinant CVA21s in the presence of 200 nM ...
<p>(A) A miR-UL112-3p deficient AD169 virus fails to down-regulate endogenous TLR2 during infection....
<p>(A) HCC subjects were grouped based on clinical HBV indices including HbsAg, HbeAg and HBV-DNA (M...
<p>(A) Analysis of miR-122 isomers identified by the deep sequencing of small RNA libraries from hum...
<p>(A) Relative Rluc:Fluc expression in Huh7.5 cells co-electroporated with full-length, replication...
<p>(A) After transfection of K562/ADM cells with mimics of miR-381, miR-495 or negative controls, or...